LLY vs MSFT
Eli Lilly and Company vs Microsoft Corporation
LLY
Eli Lilly and Company
$1052.20+2.95%
MSFT
Microsoft Corporation
$392.74-2.24%
Key Metrics Comparison
| LLY | Metric | MSFT |
|---|---|---|
| $1052.20 | Price | $392.74 |
| $992.60B | Market Cap | $2.92TBetter |
| 45.89 | P/E Ratio | 24.58Better |
| $22.93Better | EPS | $15.98 |
| +2.95%Better | Day Change | -2.24% |
| $1133.95 | 52W High | $555.45 |
| $623.78 | 52W Low | $344.79 |
| 2,455,171 | Volume | 41,581,101Better |
| 3,211,096 | Avg Volume | 32,834,928Better |
About Eli Lilly and Company
Healthcare | Drug Manufacturers - General
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a...
About Microsoft Corporation
Technology | Software - Infrastructure
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exc...